Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

293

3:39 Sinonasal Epithelial Functional and Transcriptional Responses to Long-term Highly Effective CFTR Modulator Therapy/ E.K. Vladar, Aurora, CO 3:51 The Role of Glucocorticoids on Cluster of Differentiation 151 (CD151) Expression in Influenza A Virus Replication/ Z. Lee, Kent Ridge, Singapore 4:03 Coronavirus Triggers Activation of Alveolar Epithelial ER Stress and Disruption of Surfactant Homeostasis;

3:27 COPD Education Phenotypes: Features That Impact Education for Patients With COPD/ B.J. Make, Denver, CO 3:39 Prognostic Implications of Frailty and Charlson Comorbidity Index in Patients Admitted With Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)/ D. Rozenberg, Toronto, Canada 3:51 Clinical Implications of Exercise Capacity at 3-months Post Lung Transplantation on 5-year Outcomes/ M. Khalil, Toronto, Canada 4:03 Minimal Important Difference for the Incremental and Endurance Shuttle Walk Test After a 6-week Course of Pulmonary Rehabilitation in Patients With Interstitial Lung Disease/ L. Houchen-Wolloff, Leicester, United Kingdom

Implications for COVID-19 Respiratory Failure Pathogenesis in Mice/ A. Murthy, Philadelphia, PA

BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BASIC • TRANSLATIONAL MINI SYMPOSIUM

C98

RISKY BUSINESS: PREDICTING CONSEQUENCES OF OSA

2:15 p.m. - 4:15 p.m.

Marriott Marquis Downtown Independence Ballroom, Salons E-H (Level M4)

C97

EPITHELIAL RESPONSES TO LUNG INJURY

Chairing: T. Kendzerska, MD, PhD, Ottawa, Canada S.P. Patil, MD, PhD, ATSF, Cleveland, OH V. Kundel, MD, New York, NY L.M. Donovan, MD, MS, Seattle, WA J.C. Jun, MD, Baltimore, MD Oral Presentations: 2:15 Good Adherence to CPAP Decreases Recurrent Cardiovascular Events: A Systematic Review and Individual Participant Data Meta-analysis/ M. Sanchez De La Torre, Lleida, Spain 2:27 Impact of Positive Airway Pressure (PAP)-therapy on Mortality in Obstructive Sleep Apnea (OSA): Analysis of a German Healthcare Database/ H. Woehrle, Ulm, Germany 2:39 Prevalence and Determinants of CPAP Resumption After a First CPAP Termination and Impact on All-cause Mortality: A French Nationwide Database Analysis/ J. Pépin, Grenoble Cedex 9, France 2:51 Risks of Non-benzodiazepine Benzodiazepine Receptor Agonists Among Patients With Chronic Obstructive Pulmonary Disease/ J.M. Castaneda, Seattle, WA 3:03 Combination of Ventilatory, Hypoxic, and Arousal Burden Predicts Short- and Long-term Consequences of OSA Better Than the Apnea-hypopnea Index/ S. Wickramaratne, New York, NY 3:15 Use of Machine Learning and Prediction Tools to Assess Cardiovascular Disease Risk in Obstructive Sleep Apnea/ M. Suárez-Fariñas, New York, NY

2:15 p.m. - 4:15 p.m.

Walter E. Washington Convention Center Room 102 A-B (Street Level)

Chairing: J.L. Hook, MD, New York, NY

J.P. Mizgerd, ScD, ATSF, Boston, MA R.L. Zemans, MD, Ann Arbor, MI

Featured Speaker: 2:15 Macrophage-Epithelial Interactions Driving Lung Repair/ S. Herold, Giessen, Germany Oral Presentations: 2:27 Differential Single Cell Lung Epithelial Gene Expression During Lethal and Non-lethal SARS CoV-2 Infection/ G. Bandyopadhyay, Rochester, NY 2:39 Associations of the IL-33 Signalling Pathway With Poor Clinical Outcomes and Lung Pathology in Patients With Respiratory Virus Infections at Risk of Acute Respiratory Failure/ I.C. Scott, Cambridge, United Kingdom 2:51 COVID-19 Lungs Are Dominated by Functionally Impaired Airway Basal Stem Cells With a Sustained Inflammatory Phenotype/ X. Ai, Boston, MA 3:03 Development of Alveolar Surface Proteome Enrichment (ASPEn) for Characterization of the Pre-alveolar Transitional State (PATS) Within a Murine Model of Lung Injury/ M.T. Forrester, Durham, NC 3:15 Live Imaging of Staphylococcal Retention Mechanisms in Alveoli of Influenza-infected Lungs/ S. Tang, New York, NY 3:27 Bcl-2 Interacting Killer, Bik, Promotes Influenza A Virus Replication and Severity to Flu/ S. Soni, Columbus, OH

ATS 2023 • Washington, DC